Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Revenues Rise as Company Reaches $1 Billion Mark

NEW YORK, Feb. 13 (GenomeWeb News) - Bio-Rad Laboratories of Hercules, Calif. reported a 9.5 percent increase in revenue in the fourth quarter of 2003 as it reached the $1 billion mark for full-year sales.

 

Bio-Rad reported $266.2 million in fourth-quarter revenue, up from $243 million in the year-ago period. Revenues for the Life Sciences segment in the quarter were $130.2 million, up 6.6 percent year-over-year. Net income rose by 12.2 percent from $67.9 million, or $2.70 per share, in Q4 2002; to $76.2 million, or $3.00 per share, in Q4 2003.

 

R&D expenses for the fourth quarter rose as well, from $22.9 million in 2002 to $26.4 million in 2003.

 

As of Dec. 31, 2002, Bio-Rad had cash and cash equivalents of $148.6 million.

 

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.